Understanding how p53 influences cell development and cancer formation
Official title: Mapping p53 dynamics to cell-fate outcomes in reprogramming and oncogenesis
Funded at Massachusetts Institute of Technology · NIH-10906234 · Data updated 2026-11-12
This study is looking at how a protein called p53 helps cells grow and change, especially in cancer, and it aims to find better ways to turn certain cells back into a more basic, stem cell-like state to improve treatments for cancer and healing.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | August 11, 2023 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $48,974 |
| NIH project number | 5F99CA284280-02 |
| Project ID | NIH-10906234 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with cancers related to p53 mutations or those interested in stem cell therapies.
✕Less likely to help
Patients with stable, non-cancerous conditions or those not affected by p53-related pathways may not benefit from this research.
What this research studies
This research investigates the role of the p53 protein in determining how cells develop and differentiate, particularly in the context of cancer. It explores how certain cells can revert to a stem cell-like state and how this process can be influenced by specific transcription factors. By utilizing advanced 3-D modeling techniques, the study aims to improve the efficiency of cell reprogramming, which could lead to better therapeutic strategies for cancer treatment and regenerative medicine.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for cancer and improved methods for regenerating damaged tissues.
How similar studies have gone: Previous research has shown promising results in reprogramming cells using similar approaches, indicating potential for success in this area.
Where this research is happening
-
Massachusetts Institute of Technology
Cambridge, United States Active
Researchers
- Principal investigator: Beitz, Adam Matthew — Massachusetts Institute of Technology
- Study coordinator: Beitz, Adam Matthew
Related research
Other NIH-funded projects on the same topics.
-
PhysioNet: A trusted, open data repository for clinical and physiological data
A publicly accessible platform provides curated clinical and physiological data and tools to help researchers develop and test AI models for better healthcare.
-
Dormancy in Triple-Negative Breast Cancer: How Liver and Skin Metastases Go Quiet or Reactivate
Researchers will study how dormant cancer cells in liver and skin metastases of triple-negative breast cancer become quiescent or wake up, using organ-on-chip models and single-cell analysis to map chromatin states.
-
Single-cell, label-free mapping of senescence in tissues with Raman imaging and spatial genomics
A project to map how senescent cells differ across tissues using a noninvasive Raman imaging method combined with spatial genomics.
-
Structures and dynamics of virus ion channels
This project studies the tiny channels in certain influenza and coronavirus viruses to understand how they let ions pass through and contribute to disease.
-
Prospect: Stem Cell Models for Early-Onset Colorectal Cancer Prevention
Researchers at MIT are using stem cell models to understand why colorectal cancer is rising in people under 50 and how to prevent it.
-
MATCHMAKERS: AI tools to predict TCR binding and design
Researchers are building AI tools to predict how T cell receptors recognize tumor antigens, with aims to help improve targeted immunotherapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.